238 related articles for article (PubMed ID: 32839188)
1. Evaluation of the Immunogenicity and Protective Efficacy of an Enterotoxigenic Escherichia coli CFA/I Adhesin-Heat-Labile Toxin Chimera.
O'Dowd A; Maciel M; Poole ST; Jobling MG; Rollenhagen JE; Woods CM; Sincock SA; McVeigh AL; Gregory MJ; Maves RC; Prouty MG; Holmes RK; Savarino SJ
Infect Immun; 2020 Oct; 88(11):. PubMed ID: 32839188
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of a prototype enterotoxigenic Escherichia coli adhesin vaccine in mice and nonhuman primates.
Sincock SA; Hall ER; Woods CM; O'Dowd A; Poole ST; McVeigh AL; Nunez G; Espinoza N; Miller M; Savarino SJ
Vaccine; 2016 Jan; 34(2):284-291. PubMed ID: 26597148
[TBL] [Abstract][Full Text] [Related]
3. Establishment, Validation, and Application of a New World Primate Model of Enterotoxigenic
Rollenhagen JE; Jones F; Hall E; Maves R; Nunez G; Espinoza N; O'Dowd A; Prouty MG; Savarino SJ
Infect Immun; 2019 Feb; 87(2):. PubMed ID: 30510102
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and immunological characterization of an ETEC CFA/I adhesin cholera toxin B subunit chimera.
Jobling MG; Poole ST; Rasulova-Lewis F; O'Dowd A; McVeigh AL; Balakrishnan A; Sincock SA; Prouty MG; Holmes RK; Savarino SJ
PLoS One; 2020; 15(3):e0230138. PubMed ID: 32176708
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of transcutaneous immunization as a delivery route for an enterotoxigenic E. coli adhesin-based vaccine with CfaE, the colonization factor antigen 1 (CFA/I) tip adhesin.
Rollenhagen JE; Woods CM; O'Dowd A; Poole ST; Tian JH; Guebre-Xabier M; Ellingsworth L; Prouty MG; Glenn G; Savarino SJ
Vaccine; 2019 Sep; 37(42):6134-6138. PubMed ID: 31492474
[TBL] [Abstract][Full Text] [Related]
6. Intradermal or Sublingual Delivery and Heat-Labile Enterotoxin Proteins Shape Immunologic Responses to a CFA/I Fimbria-Derived Subunit Antigen Vaccine against Enterotoxigenic Escherichia coli.
Maciel M; Bauer D; Baudier RL; Bitoun J; Clements JD; Poole ST; Smith MA; Kaminski RW; Savarino SJ; Norton EB
Infect Immun; 2019 Nov; 87(11):. PubMed ID: 31427449
[TBL] [Abstract][Full Text] [Related]
7. Preclinical Characterization of Immunogenicity and Efficacy against Diarrhea from MecVax, a Multivalent Enterotoxigenic E. coli Vaccine Candidate.
Seo H; Garcia C; Ruan X; Duan Q; Sack DA; Zhang W
Infect Immun; 2021 Jun; 89(7):e0010621. PubMed ID: 33875477
[TBL] [Abstract][Full Text] [Related]
8. A tripartite fusion, FaeG-FedF-LT(192)A2:B, of enterotoxigenic Escherichia coli (ETEC) elicits antibodies that neutralize cholera toxin, inhibit adherence of K88 (F4) and F18 fimbriae, and protect pigs against K88ac/heat-labile toxin infection.
Ruan X; Liu M; Casey TA; Zhang W
Clin Vaccine Immunol; 2011 Oct; 18(10):1593-9. PubMed ID: 21813665
[TBL] [Abstract][Full Text] [Related]
9. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.
Holmgren J; Bourgeois L; Carlin N; Clements J; Gustafsson B; Lundgren A; Nygren E; Tobias J; Walker R; Svennerholm AM
Vaccine; 2013 May; 31(20):2457-64. PubMed ID: 23541621
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of recombinant Lactobacillus casei-expressing F4 (K88) fimbrial adhesin FaeG in conjunction with a heat-labile enterotoxin A (LTAK63) and heat-labile enterotoxin B (LTB) of enterotoxigenic Escherichia coli as an oral adjuvant in mice.
Yu M; Qi R; Chen C; Yin J; Ma S; Shi W; Wu Y; Ge J; Jiang Y; Tang L; Xu Y; Li Y
J Appl Microbiol; 2017 Feb; 122(2):506-515. PubMed ID: 27860074
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the immunogenicity and protective efficacy of a recombinant CS6-based ETEC vaccine in an Aotus nancymaae CS6 + ETEC challenge model.
Ramakrishnan A; Joseph SS; Reynolds ND; Poncet D; Maciel M; Nunez G; Espinoza N; Nieto M; Castillo R; Royal JM; Poole S; McVeigh A; Rollenhagen JE; Heinrichs J; Prouty MG; Simons MP; Renauld-Mongénie G; Savarino SJ
Vaccine; 2021 Jan; 39(3):487-494. PubMed ID: 33357957
[TBL] [Abstract][Full Text] [Related]
12. Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein.
Lundgren A; Leach S; Tobias J; Carlin N; Gustafsson B; Jertborn M; Bourgeois L; Walker R; Holmgren J; Svennerholm AM
Vaccine; 2013 Feb; 31(8):1163-70. PubMed ID: 23306362
[TBL] [Abstract][Full Text] [Related]
13. Maternal vaccination with a fimbrial tip adhesin and passive protection of neonatal mice against lethal human enterotoxigenic Escherichia coli challenge.
Luiz WB; Rodrigues JF; Crabb JH; Savarino SJ; Ferreira LC
Infect Immun; 2015 Dec; 83(12):4555-64. PubMed ID: 26371126
[TBL] [Abstract][Full Text] [Related]
14. Enterotoxigenic Escherichia coli Adhesin-Toxoid Multiepitope Fusion Antigen CFA/I/II/IV-3xSTa
Nandre R; Ruan X; Lu T; Duan Q; Sack D; Zhang W
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263112
[TBL] [Abstract][Full Text] [Related]
15. Antibodies induced by enterotoxigenic Escherichia coli (ETEC) adhesin major structural subunit and minor tip adhesin subunit equivalently inhibit bacteria adherence in vitro.
Seo H; Nandre RM; Nietfeld J; Chen Z; Duan Q; Zhang W
PLoS One; 2019; 14(5):e0216076. PubMed ID: 31042746
[TBL] [Abstract][Full Text] [Related]
16. A First in Human Clinical Trial Assessing the Safety and Immunogenicity of Two Intradermally Delivered Enterotoxigenic
Gutiérrez RL; Riddle MS; Porter CK; Maciel M; Poole ST; Laird RM; Lane M; Turiansky GW; Jarell A; Savarino SJ
Microorganisms; 2023 Nov; 11(11):. PubMed ID: 38004700
[TBL] [Abstract][Full Text] [Related]
17. Intramuscularly Administered Enterotoxigenic
Upadhyay I; Lauder KL; Li S; Ptacek G; Zhang W
Microbiol Spectr; 2022 Aug; 10(4):e0147322. PubMed ID: 35762781
[TBL] [Abstract][Full Text] [Related]
18. Identification and Characterization of Human Monoclonal Antibodies for Immunoprophylaxis against Enterotoxigenic Escherichia coli Infection.
Giuntini S; Stoppato M; Sedic M; Ejemel M; Pondish JR; Wisheart D; Schiller ZA; Thomas WD; Barry EM; Cavacini LA; Klempner MS; Wang Y
Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29866909
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Mucosal Immune Responses to Enterotoxigenic Escherichia coli Vaccine Antigens in a Human Challenge Model: Response Profiles after Primary Infection and Homologous Rechallenge with Strain H10407.
Chakraborty S; Harro C; DeNearing B; Ram M; Feller A; Cage A; Bauers N; Bourgeois AL; Walker R; Sack DA
Clin Vaccine Immunol; 2016 Jan; 23(1):55-64. PubMed ID: 26581889
[TBL] [Abstract][Full Text] [Related]
20. MecVax supplemented with CFA MEFA-II induces functional antibodies against 12 adhesins (CFA/I, CS1-CS7, CS12, CS14, CS17, and CS21) and 2 toxins (STa, LT) of enterotoxigenic
Zhang C; Li S; Upadhyay I; Lauder KL; Sack DA; Zhang W
Microbiol Spectr; 2024 Apr; 12(4):e0415323. PubMed ID: 38364078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
